Standard Chemical & Pharmaceutical Co. Ltd.

TWSE:1720 Stock Report

Market Cap: NT$10.9b

Standard Chemical & Pharmaceutical Dividends and Buybacks

Dividend criteria checks 4/6

Standard Chemical & Pharmaceutical is a dividend paying company with a current yield of 4.42% that is well covered by earnings.

Key information

4.4%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growth0.4%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareNT$2.700
Payout ratio57%

Recent dividend and buyback updates

Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Jul 29
Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Recent updates

Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Jul 29
Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

Apr 13
If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Mar 14
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Mar 01
Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Feb 16
Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Feb 03
Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 19
Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Jan 04
Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

Dec 22
Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Dec 08
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Nov 26
Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 1720's dividend payments have been volatile in the past 10 years.

Growing Dividend: 1720's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Standard Chemical & Pharmaceutical Dividend Yield vs Market
How does 1720 dividend yield compare to the market?
SegmentDividend Yield
Company (1720)4.4%
Market Bottom 25% (TW)1.8%
Market Top 25% (TW)4.6%
Industry Average (Pharmaceuticals)2.3%
Analyst forecast (1720) (up to 3 years)n/a

Notable Dividend: 1720's dividend (4.42%) is higher than the bottom 25% of dividend payers in the TW market (1.8%).

High Dividend: 1720's dividend (4.42%) is low compared to the top 25% of dividend payers in the TW market (4.58%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (56.9%), 1720's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (44.8%), 1720's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:39
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Standard Chemical & Pharmaceutical Co. Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Qing Rong LinE.Sun Securities Investment Consulting Co. Ltd.
Regina LeeIBTS Investment Consulting Co., Ltd.
Li-chun ChangJih Sun Securities Investment Consulting Co., Ltd.